Trial Site Detail

 

Drug:
Imatinib + Regorafenib
Trial:
A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) (ALT GIST)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

Norwegian Radium Hospital

     
Oslo , N-0310
Norway

 

Principal Investigator:
Contact:
ALTGIST Trial Coordinator +6129562500 altgist@ctc.usyd.edu.au
Activation Status of this Site:
Active
Notes about this Site:
Norwegian Radium Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.